Author Archives: admin


MS-UK | Stem cells And MS Research

StemGenex continues to announce groundbreaking stem cell therapies for MS patients(03/12/13)

New targeted stem cell therapy looks to improve MS patients dealing with incontinence complications.

StemGenex, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases today announced the newest therapy to assist patients diagnosed with Multiple Sclerosis.

According to the National MS Society, at least 80% of people with MS experience bladder dysfunction. StemGenex believes a new therapy delivering adipose derived mesenchymal cells directly to the bladder may reduce the inflammation that is causing the patients incontinence.

Direct bladder targeting is the latest in a series of targeted therapies StemGenex plans to announce in the next few months for patients dealing with degenerative diseases such as Parkinsons, Alzheimers, COPD and of course Multiple Sclerosis. Earlier this month StemGenex announced a new intranasal stem cell therapy. The goal of this new technique is to encourage more stem cells to travel through the blood brain barrier to target the damage caused by MS.

Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with Multiple Sclerosis and other degenerative neurological diseases. StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative neurological diseases including Parkinsons and Alzheimers disease, stroke recovery and others. Rita Alexander, founder of StemGenex and the companys first stem cell patient, insists that all patients be treated like they are one of our loved ones. "Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus."

Source: Copyright 1997-2013, Vocus PRW Holdings, LLC. Vocus, PRWeb (03/12/13)

A team of Ottawa doctors is preparing to publish a full report on its breakthrough multiple sclerosis treatment study that has so far eliminated the disease in those treated.

The experimental study began about 13 years ago as a last resort for patients who fail to improve on drug therapy and who suffer severe symptoms of MS. Snippets of the results have been published here and there, said, neurologist Dr. Mark Freedman, one of the leads of the program at The Ottawa Hospital, but its never been published in its entirety.

No specific date has been set for its release, but the teams findings are far from secret. With MS not returning in any of the 24 participants, patient success stories appear in news media across the country. Since the original studys completion, about another dozen patients have been treated with all of them showing the same results.

Go here to see the original:
MS-UK | Stem cells And MS Research

Stem-Cell Therapy and Repair after Heart Attack and Heart Failure

Stem Cell Therapy: Helping the Body Heal Itself

Stem cells are natures own transformers. When the body is injured, stem cells travel the scene of the accident. Some come from the bone marrow, a modest number of others, from the heart itself. Additionally, theyre not all the same. There, they may help heal damaged tissue. They do this by secreting local hormones to rescue damaged heart cells and occasionally turning into heart muscle cells themselves. Stem cells do a fairly good job. But they could do better for some reason, the heart stops signaling for heart cells after only a week or so after the damage has occurred, leaving the repair job mostly undone. The partially repaired tissue becomes a burden to the heart, forcing it to work harder and less efficiently, leading to heart failure.

Initial research used a patients own stem cells, derived from the bone marrow, mainly because they were readily available and had worked in animal studies. Careful study revealed only a very modest benefit, so researchers have moved on to evaluate more promising approaches, including:

No matter what you may read, stem cell therapy for damaged hearts has yet to be proven fully safe and beneficial. It is important to know that many patients are not receiving the most current and optimal therapies available for their heart failure. If you have heart failure, and wondering about treatment options, an evaluation or a second opinion at a Center of Excellence can be worthwhile.

Randomized clinical trials evaluating these different approaches typically allow enrollment of only a few patients from each hospital, and hence what may be available at the Cleveland Clinic varies from time to time. To inquire about current trials, please call 866-289-6911 and speak to our Resource Nurses.

Cleveland Clinic is a large referral center for advanced heart disease and heart failure we offer a wide range of therapies including medications, devices and surgery. Patients will be evaluated for the treatments that best address their condition. Whether patients meet the criteria for stem cell therapy or not, they will be offered the most advanced array of treatment options.

Reviewed: 04/13

See the original post here:
Stem-Cell Therapy and Repair after Heart Attack and Heart Failure

Perelman School of Medicine at the University of Pennsylvania

Activating Pathway Could Restart Hair Growth in Dormant Hair Follicles, Penn Study Suggests

5 Dec 2013A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, according to researchers with the Perelman School of Medicine at the... Read more

4 Dec 2013Brendan G. Carr, MD, MA, MS, assistant professor of Emergency Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennslyvania, has been named as the director of the Emergency Care Coordination Center (ECCC). Read more

3 Dec 2013Compared to traditional mammography, 3D mammographyknown as digital breast tomosynthesisfound 22 percent more breast cancers and led to fewer call backs in a large screening study at the Hospital of the University of Pennsylvania (HUP), researchers reported today at the annual meeting of th... Read more

2 Dec 2013A new brain connectivity study from Penn Medicine published today in the Proceedings of National Academy of Sciences found striking differences in the neural wiring of men and women thats lending credence to some commonly-held beliefs about their behavior. Read more

29 Nov 2013A new, first-of-its-kind study by researchers at the Perelman School of Medicine at the University of Pennsylvania seeks to learn whether men with prostate cancer who are undergoing radiation therapy can benefit from yoga. The study, led by Neha Vapiwala, MD, assistant professor of Radiation... Read more

Continue reading here:
Perelman School of Medicine at the University of Pennsylvania

Cell – Official Site

Cell Press celebrates the achievements of James E. Rothman, Randy W. Schekman, and Neuron Editorial Board member Thomas C. Sdhof, recipients of the 2013 Nobel Prize in Physiology or Medicine and congratulates Structure Editorial Board member Martin Karplus, Biophysical Journal Editorial Board member Michael Levitt, and Arieh Warshel , the recipients of the 2013 Nobel Prize in Chemistry. Read the award winners' research published in Cell Press journals FREE.

KI @ MITImage Awards II: Scientific data comes in many flavors and types, but a special place is reserved for images. Micrographs, MRI scans, and other biomedical images serve as windows through which experts and nonscientists alike can glimpse otherwise invisible biological worlds. The MIT Koch Institute Image Awards were established to recognize and publicly display these extraordinary visuals. This show highlights the 2013 Koch Image Award Winners.

View more slideshows.

Cell Picture Show thanks our sponsor.

Please join us for a FREE webinar and hear Angela Stathopoulos and Roberto Weigert discuss the processes that shape the developing embryo and form biological structures as well as the latest imaging techniques in this field.

Please join us for a FREE webinar and hear Dr. Carlo Croce and Dr. Joshua Mendell share their latest insights into the role of miRNAs in cancer.

Click here to view Reviews, Perspectives, and Forum articles on the progress and prospects for therapeutic application of induced pluripotent stem cells.

More here:
Cell - Official Site

Stem Cell Treatments

Orange County, California (PRWEB) December 02, 2013 Stem cell treatments for back pain from arthritis are now being offered at top West Coast stem cell clinic, TeleHealth. The outpatient, low risk treatments are provided by Board Certified doctors with extensive experience in stem cell therapy. Continue reading

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics. Continue reading

A single copy of this article may be reprinted for personal, noncommercial use only. A stem cell (blood or marrow) transplant is the infusion, or injection, of healthy stem cells into your body to replace damaged or diseased stem cells. A stem cell transplant may be necessary if your bone marrow stops working and doesnt produce enough healthy stem cells Continue reading

IRVINE, Calif. California Stem Cell, Inc. Continue reading

Go here to see the original:
Stem Cell Treatments

Stem cell therapy: Facts worth noting – Worldnews.com

The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.

The FDA also enforces other laws, notably Section 361 of the Public Health Service Act and associated regulations, many of which are not directly related to food or drugs. These include sanitation requirements on interstate travel and control of disease on products ranging from certain household pets to sperm donation for assisted reproduction.

The FDA is led by the Commissioner of Food and Drugs, appointed by the President with the advice and consent of the Senate. The Commissioner reports to the Secretary of Health and Human Services. The 21st and current Commissioner is Dr. Margaret A. Hamburg. She has served as Commissioner since February 2009.

The FDA has its headquarters at White Oak, Maryland.[3] The agency also has 223 field offices and 13laboratories located throughout the 50states, the United States Virgin Islands, and Puerto Rico.[4] In 2008, the FDA started opening offices in foreign countries, including China, India, Costa Rica, Chile, Belgium, and the United Kingdom.[5]

The FDA comprises several offices and centers. There are

In recent years, the agency began undertaking a large-scale effort to consolidate its operations in the Washington Metropolitan Area from its main headquarters in Rockville and several fragmented office buildings in the vicinity to the former site of the Naval Ordnance Laboratory in the White Oak area of Silver Spring, Maryland.[3][6] When the FDA arrived, the site was renamed from the White Oak Naval Surface Warfare Center to the Federal Research Center at White Oak. The first building, the Life Sciences Laboratory, was dedicated and opened with 104 employees on the campus in December 2003. The project is slated to be completed by 2013.

While most of the Centers are located around the Washington, D.C., area as part of the Headquarters divisions, two offices - the Office of Regulatory Affairs (ORA) and the Office of Criminal Investigations (OCI) - are primarily field offices with a workforce spread across the country.

The Office of Regulatory Affairs is considered the "eyes and ears" of the agency, conducting the vast majority of the FDA's work in the field. Consumer Safety Officers, more commonly called Investigators, are the individuals who inspect production and warehousing facilities, investigate complaints, illnesses, or outbreaks, and review documentation in the case of medical devices, drugs, biological products, and other items where it may be difficult to conduct a physical examination or take a physical sample of the product. The Office of Regulatory Affairs is divided into five regions, which are further divided into 13 districts. Districts are based roughly on the geographic divisions of the federal court system. Each district comprises a main district office, and a number of Resident Posts, which are FDA offices located away from the district office to serve a particular geographic area. ORA also includes the Agency's network of laboratories, which analyze any physical samples taken. Though samples are usually food-related, some laboratories are equipped to analyze drugs, cosmetics, and radiation-emitting devices.

The Office of Criminal Investigations was established in 1991 to investigate criminal cases. Unlike ORA Investigators, OCI Special Agents are armed, and are not focused on the technical aspects of the regulated industries. OCI agents pursue and develop cases where criminal actions have occurred, such as fraudulent claims, or knowingly and willfully shipping known adulterated goods in interstate commerce. In many cases, OCI will pursue cases where Title 18 violations have occurred (e.g. conspiracy, false statements, wire fraud, mail fraud), in addition to prohibited acts as defined in Chapter III of the FD&C Act. OCI Special Agents often come from other criminal investigations backgrounds, and work closely with the Federal Bureau of Investigation, Assistant Attorney General, and even Interpol. OCI will receive cases from a variety of sources, including ORA, local agencies, and the FBI, and will work with ORA investigators to help develop the technical and science-based aspects of a case. OCI is a smaller branch, comprising about 200 agents nationwide.

The FDA frequently works in conjunction with other federal agencies including the Department of Agriculture, Drug Enforcement Administration, Customs and Border Protection, and Consumer Product Safety Commission. Often local and state government agencies also work in cooperation with the FDA to provide regulatory inspections and enforcement action.

Read more:
Stem cell therapy: Facts worth noting - Worldnews.com

Stem Cell Breakthrough Brings Prostate Cancer Treatment Closer …

Adult stem cells are tissue-specific regenerative cells that replace diseased or damaged cells in the body's organs.

Researchers found that tumours can start in basal stem cells that evolve to luminal-like cells. This means that the source of the disease they wish to target with therapy - the tumour stem cell - can change over time.

"People have begun to think about cancers as being driven by stem cells in the same way that many of our adult organs are maintained by dedicated stem cells," said Goldstein, "based on this new understanding, a lot of excitement surrounds the concept of going right to the root of the tumor and targeting those stem cells to eradicate the cancer."

In patients with aggressive prostate cancer who are being treated with anti-androgen therapy, the basal stem cells that start the cancer look different from the luminal cells that maintain the aggressive disease, and in turn the tumour stem cells that remain after the anti-androgen treatment look different from the previous two.

This means that for targeting treatments, researchers need to identify cell types that evolve as the disease and its treatment progress.

The study was published in the Proceedings of the National Academy of Sciences.

View original post here:
Stem Cell Breakthrough Brings Prostate Cancer Treatment Closer ...

West Coast Stem Cell Clinic, TeleHealth, Now Offering Stem …

Stem cell treatments for back pain from arthritis are now being offered at top West Coast stem cell clinic, TeleHealth. The outpatient, low risk treatments are provided by Board Certified doctors with extensive experience in stem cell therapy.

Orange County, California (PRWEB) December 02, 2013

Stem cell treatments for back pain from arthritis are now being offered at top West Coast stem cell clinic, TeleHealth. The outpatient, low risk treatments are provided by Board Certified doctors with extensive experience in stem cell therapy. For more information and scheduling call (888) 828-4575.

Traditional treatments for arthritic spinal joints involve interventional procedures that do a great job at reducing pain, however, they do not alter the course of the condition. They act as a proverbial "band aid", and are necessary every so often once pain returns.

Stem cell injections, on the other hand, have the potential to provide pain relief while possible regenerating some of the damaged tissue. Initial small studies have shown this potential for cartilage regeneration in animals, while small human studies have demonstrated excellent clinical outcomes.

TeleHealth offers these stem cell injections in an outpatient setting with Board Certified doctors. The injection material is processed from a persons own fat or bone marrow, so there is very little risk of infection or adverse event.

In addition to offering stem cell therapy for back pain, TeleHealth also offers the treatments for extremity joint arthritis in the knee, shoulder, hip, ankle, elbow and wrist. Additionally, tendonitis of the elbow, shoulder, Achilles and knee typically responds very well to the treatments. Non-healing fractures are indicated as well.

For more information and scheduling call (888) 828-4575.

For the original version on PRWeb visit: http://www.prweb.com/releases/stemcellsforbackpain/californiastemcells/prweb11376304.htm

Search BioPortfolio:

Go here to see the original:
West Coast Stem Cell Clinic, TeleHealth, Now Offering Stem ...

[International version] Linda van Laake: "We want to work together to improve stem cell treatment" – Video


[International version] Linda van Laake: "We want to work together to improve stem cell treatment"
Dr Linda van Laake is assistant professor and specialist registrar in Cardiology at the University Medical Center Utrecht and Hubrecht Institute. She carries...

By: UniversiteitUtrecht

Read the original post:
[International version] Linda van Laake: "We want to work together to improve stem cell treatment" - Video